Bullish http://seekingalpha.com/article/3967368-parnell-pharmaceuticals-holdings-parn-ceo-robert-joseph-q1-2016-results-earnings-call

Looking For A Monday Morning Spike! 

Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) is up by 18% in late morning trading after the nano-cap reported its first quarter results. For the three months ended March 31, Parnell grew revenue by 43% year-over-year to $2.2 million. U.S. sales for the company’s production animal unit came in at $1.3 million. CEO Robert Joseph went over the strong results in a press release:

 

“Parnell had a fantastic first quarter in 2016 with strong revenue growth across our whole business. We were particularly pleased with our US Production business which performed above our expectations as did our Australian Companion Animal business. Our US Companion team continued to establish a strong footprint in the market with Fetch™ (our digital app) and Glyde™ (our nutraceutical for osteoarthritis, or OA). After several months of negotiations we have now agreed upon terms with a major multi-national pharmaceutical company on a contract manufacturing agreement that we expect to sign as early as next week.”